Zannes Maria 4
4 · bioAffinity Technologies, Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Zannes Maria
DirectorPresident & CEO
Transactions
- Award
Common Stock
2024-01-31+23,885→ 164,658 total
Footnotes (1)
- [F1]Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024.